Examining serum ferritin levels in patients with chronic kidney disease
Variability of Serum Ferritin in CKD Patients and How These Variables May Affect the Treatment Decisions With Iron
This study is trying to see how changes in iron levels in the blood affect treatment decisions for people with chronic kidney disease who aren't on dialysis.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 55 (estimated) |
| Ages | 18 Years to 50 Years |
| Sex | All |
| Sponsor | Assiut University Academic / other |
| Locations | 1 site (Assiut) |
| Trial ID | NCT05947552 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the variability of serum ferritin levels in patients with chronic kidney disease (CKD) stages 3 to 5 who are not on dialysis. It aims to understand how these variations may influence treatment decisions regarding iron supplementation. Given that serum ferritin can be affected by inflammation, which is common in CKD, the study seeks to clarify its role as an indicator of iron deficiency in this population. The findings could help refine treatment strategies for managing iron levels in CKD patients.
Who should consider this trial
Good fit: Ideal candidates for this study are CKD patients in stages 3 to 5 who are not undergoing dialysis.
Not a fit: Patients with inflammatory chronic diseases, autoimmune disorders, liver diseases, malignancies, or infections may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the management of iron deficiency in CKD patients, leading to better treatment outcomes.
How similar studies have performed: While the variability of serum ferritin in CKD has been noted, this specific observational approach to understanding its implications for treatment decisions is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ALL CKD patients stage 3 to 5 not on dialysis Exclusion Criteria: * inflammatory chronic diseases IDA Autoimmune disorders Liver diseases Malignancy Infections
Where this trial is running
Assiut
- Assiut university — Assiut, Egypt (Recruiting)
Study contacts
- Study coordinator: Reham Ma Osman, doctor
- Email: rehamaskary1234@gmail.com
- Phone: 01065934817
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.